Preclinical Evaluation of Radioiodinated Hoechst 33258 for Early Prediction of Tumor Response to Treatment of Vascular-Disrupting Agents

This study aimed to explore the use of (131)I-Hoechst 33258 ((131)I-H33258) for early prediction of tumor response to vascular-disrupting agents (VDAs) with combretastatin-A4 phosphate (CA4P) as a representative. Necrosis avidity of (131)I-H33258 was evaluated in mouse models with muscle necrosis an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Contrast Media Mol Imaging
Autores principales: Zhang, Dongjian, Gao, Meng, Yao, Nan, Jiang, Cuihua, Liu, Wei, Li, Tiannv, Song, Shaoli, Huang, Dejian, Yin, Zhiqi, Qiu, Yunliang, Jin, Qiaomei
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846351/
https://ncbi.nlm.nih.gov/pubmed/29681781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5237950
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares